nach oben

Erschienen in:

19.11.2021 | Topic Review

Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes

verfasst von: Paolo Palmisciano, Tarek Y. El Ahmadieh, Ali S. Haider, Othman Bin Alamer, Faith C. Robertson, Aaron R. Plitt, Salah G. Aoun, Kenny Yu, Aaron Cohen-Gadol, Nelson S. Moss, Toral R. Patel, Raymond Sawaya

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Thalamic gliomas are rare neoplasms that pose significant surgical challenges. The literature is limited to single-institution retrospective case series. We systematically review the literature and describe the clinical characteristics, treatment strategies, and survival outcomes of adult thalamic gliomas.

Methods

Relevant articles were identified on PubMed, Scopus, and Cochrane databases. Papers containing cases of adult thalamic gliomas with clinical outcome data were included. A comprehensive review of clinical characteristics and survival analysis was conducted.

Results

We included 25 studies comprising 617 patients. The median age was 45 years (male = 58.6%). Glioblastoma was the most frequent histological type (47.2%), and 82 tumors were H3 K27M-mutant. Motor deficit was the most common presenting symptom (51.8%). Surgical resection was performed in 69.1% of cases while adjuvant chemotherapy and radiotherapy were administered in 56.3% and 72.6%, respectively. Other treatments included laser interstitial thermal therapy, which was performed in 15 patients (2.4%). The lesion laterality (P = 0.754) and the surgical approach (P = 0.111) did not correlate with overall survival. The median progression-free survival was 9 months, and the overall two-year survival rate was 19.7%. The two-year survival rates of low-grade and high-grade thalamic gliomas were 31.0% and 16.5%, respectively. H3 K27M-mutant gliomas showed worse overall survival (P = 0.017).

Conclusion

Adult thalamic gliomas are associated with poor survival. Complete surgical resection is associated with improved survival rates but is not always feasible. H3 K27M mutation is associated with worse survival and a more aggressive approach should be considered for mutant neoplasms.

Nur mit Berechtigung zugänglich

Niu X, Wang T, Zhou X et al (2020) Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years. J Neurooncol 147:377–386. https://doi.org/10.1007/s11060-020-03430-xCrossRefPubMed

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1CrossRefPubMed

Karremann M, Gielen GH, Hoffmann M et al (2018) Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol 20:123–131. https://doi.org/10.1093/neuonc/nox149CrossRefPubMed

Kelly PJ (1989) Stereotactic biopsy and resection of thalamic astrocytomas. Neurosurgery 25:185–195. https://doi.org/10.1227/00006123-198908000-00006CrossRefPubMed

Kis D, Máté A, Kincses ZT et al (2014) The role of probabilistic tractography in the surgical treatment of thalamic gliomas. Oper Neurosurg 10:262–272. https://doi.org/10.1227/NEU.0000000000000333CrossRef

Qinglong G, Wei H, Biwu W et al (2020) Lateral or medial surgical approaches for thalamic gliomas resection? World Neurosurg 136:e90–e107. https://doi.org/10.1016/j.wneu.2019.11.108CrossRefPubMed

Sanai N, Berger MS (2018) Surgical oncology for gliomas: the state of the art. Nat Rev Clin Oncol 15:112–125. https://doi.org/10.1038/nrclinonc.2017.171CrossRefPubMed

Serra C, Türe H, Yaltırık CK et al (2020) Microneurosurgical removal of thalamic lesions: surgical results and considerations from a large, single-surgeon consecutive series. J Neurosurg. https://doi.org/10.3171/2020.6.JNS20524CrossRefPubMed

Murayi R, Borghei-Razavi H, Barnett GH, Mohammadi AM (2020) Laser interstitial thermal therapy in the treatment of thalamic brain tumors: a case series. Oper Neurosurg 19:641–650. https://doi.org/10.1093/ons/opaa206CrossRef

10.

Li Z, Wu H, Wu B et al (2020) Long term follow-up and outcomes in adult patients with thalamic gliomas. Clin Neurol Neurosurg 195:105888. https://doi.org/10.1016/j.clineuro.2020.105888CrossRefPubMed

11.

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

12.

J Howick, I Chalmers, P Glasziou, T Greenhalgh, C Heneghan, A Liberati, I Moschetti, B Phillips (2011) Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence (background document). In: Oxford Cent. Evidence-Based Med. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Accessed 1 Feb 2021

13.

NIH: study quality assessment tools—quality assessment tool for case series studies. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 1 Feb 2021

14.

Menon G, Nair S, Sudhir J et al (2010) Bilateral thalamic lesions. Br J Neurosurg 24:566–571. https://doi.org/10.3109/02688691003777915CrossRefPubMed

15.

Aihara K, Mukasa A, Gotoh K et al (2014) H3F3A K27M mutations in thalamic gliomas from young adult patients. Neuro Oncol 16:140–146. https://doi.org/10.1093/neuonc/not144CrossRefPubMed

16.

Hawasli AH, Bagade S, Shimony JS et al (2013) magnetic resonance imaging-guided focused laser interstitial thermal therapy for intracranial lesions. Neurosurgery 73:1007–1017. https://doi.org/10.1227/NEU.0000000000000144CrossRefPubMed

17.

Waqar M, Hanif S, Rathi N et al (2014) Diagnostic challenges, management and outcomes of midline low-grade gliomas. J Neurooncol 120:389–398. https://doi.org/10.1007/s11060-014-1563-6CrossRefPubMed

18.

Cao L, Li C, Zhang Y, Gui S (2015) Surgical resection of unilateral thalamic tumors in adults: approaches and outcomes. BMC Neurol 15:229. https://doi.org/10.1186/s12883-015-0487-xCrossRefPubMedPubMedCentral

19.

Saito R, Kumabe T, Kanamori M et al (2017) Distant recurrences limit the survival of patients with thalamic high-grade gliomas after successful resection. Neurosurg Rev 40:469–477. https://doi.org/10.1007/s10143-016-0804-xCrossRefPubMed

20.

Zhang P, Wang X, Ji N et al (2016) Clinical, radiological, and pathological features of 33 adult unilateral thalamic gliomas. World J Surg Oncol 14:78. https://doi.org/10.1186/s12957-016-0820-xCrossRefPubMedPubMedCentral

21.

Akiyama Y, Ohtaki S, Komatsu K et al (2017) Intraoperative mapping and monitoring of the pyramidal tract using endoscopic depth electrodes. World Neurosurg 105:14–19. https://doi.org/10.1016/j.wneu.2017.05.048CrossRefPubMed

22.

Esquenazi Y, Moussazadeh N, Link TW et al (2018) Thalamic glioblastoma: clinical presentation, management strategies, and outcomes. Neurosurgery 83:76–85. https://doi.org/10.1093/neuros/nyx349CrossRefPubMed

23.

Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro Oncol 19:1127–1134. https://doi.org/10.1093/neuonc/now274CrossRefPubMedPubMedCentral

24.

Niu X, Wang T, Yang Y et al (2018) Prognostic factors for the survival outcome of bilateral thalamic glioma: an integrated survival analysis. World Neurosurg 110:e222–e230. https://doi.org/10.1016/j.wneu.2017.10.132CrossRefPubMed

25.

Fukami S, Nakajima N, Okada H et al (2018) Pathologic findings and clinical course of midline paraventricular gliomas diagnosed using a neuroendoscope. World Neurosurg 114:e366–e377. https://doi.org/10.1016/j.wneu.2018.02.185CrossRefPubMed

26.

El Ahmadieh TY, Plitt A, Kafka B et al (2019) H3 K27M mutations in thalamic pilocytic astrocytomas with anaplasia. World Neurosurg 124:87–92. https://doi.org/10.1016/j.wneu.2018.12.147CrossRef

27.

Liu Y, Zhang Y, Hua W et al (2019) Clinical and molecular characteristics of thalamic gliomas: retrospective report of 26 cases. World Neurosurg 126:e1169–e1182. https://doi.org/10.1016/j.wneu.2019.03.061CrossRefPubMed

28.

Dono A, Takayasu T, Ballester LY, Esquenazi Y (2020) Adult diffuse midline gliomas: clinical, radiological, and genetic characteristics. J Clin Neurosci 82:1–8. https://doi.org/10.1016/j.jocn.2020.10.005CrossRefPubMedPubMedCentral

29.

Kelly PJ, Kall BA, Goerss S, Earnest F (1986) Computer-assisted stereotaxic laser resection of intra-axial brain neoplasms. J Neurosurg 64:427–439. https://doi.org/10.3171/jns.1986.64.3.0427CrossRefPubMed

30.

Hakim R, Loeffler JS, Anthony DC, Black PM (1997) Gangliogliomas in adults. Cancer 79:127–131. https://doi.org/10.1002/(SICI)1097-0142(19970101)79:1%3c127::AID-CNCR18%3e3.0.CO;2-6CrossRefPubMed

31.

Steiger H-J, Götz C, Schmid-Elsaesser R, Stummer W (2000) Thalamic astrocytomas: surgical anatomy and results of a pilot series using maximum microsurgical removal. Acta Neurochir 142:1327–1337. https://doi.org/10.1007/s007010070001CrossRefPubMed

32.

Gallina P, Francescon P, Cavedon C et al (2002) Stereotactic interstitial radiosurgery with a miniature X-ray device in the minimally invasive treatment of selected tumors in the thalamus and the Basal Ganglia. Stereotact Funct Neurosurg 79:202–213. https://doi.org/10.1159/000070833CrossRefPubMed

33.

Puget S, Crimmins DW, Garnett MR et al (2007) Thalamic tumors in children: a reappraisal. J Neurosurg Pediatr 106:354–362. https://doi.org/10.3171/ped.2007.106.5.354CrossRef

34.

Ostrom QT, Patil N, Cioffi G et al (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol 22:iv1–iv96. https://doi.org/10.1093/neuonc/noaa200CrossRefPubMedPubMedCentral

35.

Brown TJ, Brennan MC, Li M et al (2016) Association of the extent of resection with survival in glioblastoma. JAMA Oncol 2:1460. https://doi.org/10.1001/jamaoncol.2016.1373CrossRefPubMedPubMedCentral

36.

Claus EB, Walsh KM, Wiencke JK et al (2015) Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus 38:E6. https://doi.org/10.3171/2014.10.FOCUS12367CrossRefPubMedPubMedCentral

37.

Ostrom QT, Cote DJ, Ascha M et al (2018) Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol 4:1254–1262. https://doi.org/10.1001/jamaoncol.2018.1789CrossRefPubMedPubMedCentral

38.

Bender S, Tang Y, Lindroth AM et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24:660–672. https://doi.org/10.1016/j.ccr.2013.10.006CrossRefPubMed

39.

Fontebasso AM, Liu X-Y, Sturm D, Jabado N (2013) Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail. Brain Pathol 23:210–216. https://doi.org/10.1111/bpa.12023CrossRefPubMedPubMedCentral

40.

Lewis PW, Muller MM, Koletsky MS et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340:857–861. https://doi.org/10.1126/science.1232245CrossRefPubMedPubMedCentral

41.

Bernstein M, Hoffman HJ, Halliday WC et al (1984) Thalamic tumors in children. J Neurosurg 61:649–656. https://doi.org/10.3171/jns.1984.61.4.0649CrossRefPubMed

42.

Weller M, van den Bent M, Preusser M et al (2020) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. https://doi.org/10.1038/s41571-020-00447-zCrossRefPubMedPubMedCentral

43.

Stark AM, Nabavi A, Mehdorn HM, Blömer U (2005) Glioblastoma multiforme—report of 267 cases treated at a single institution. Surg Neurol 63:162–169. https://doi.org/10.1016/j.surneu.2004.01.028CrossRefPubMed

44.

Hervey-Jumper SL, Berger MS (2016) Maximizing safe resection of low- and high-grade glioma. J Neurooncol 130:269–282. https://doi.org/10.1007/s11060-016-2110-4CrossRefPubMed

45.

MSK-IMPACT: A targeted test for mutations in both rare and common cancers. https://www.mskcc.org/msk-impact. Accessed 27 Apr 2021

Titel: Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes
verfasst von: Paolo Palmisciano
Tarek Y. El Ahmadieh
Ali S. Haider
Othman Bin Alamer
Faith C. Robertson
Aaron R. Plitt
Salah G. Aoun
Kenny Yu
Aaron Cohen-Gadol
Nelson S. Moss
Toral R. Patel
Raymond Sawaya
Publikationsdatum: 19.11.2021
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2021
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-021-03898-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas

Correction to: Surgical strategies for older patients with glioblastoma

Surgical strategies for older patients with glioblastoma

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience